What's Happening?
At the Axtria Ignite 2025 summit in Princeton, New Jersey, Madhavi Ramakrishna, GSK's SVP of enterprise AI and chief digital and technology officer, shared insights on AI transformation within the organization. Ramakrishna, a recipient of the Axtria Ignite Leadership Award, highlighted the transition to agentic AI and its cultural drivers. She emphasized the significant impact AI is having on research and development at GSK, while also addressing the challenges of technology transformation. The summit provided a platform for discussing leadership and cultural aspects of AI integration in business processes.
Why It's Important?
The integration of AI in organizations like GSK is crucial for advancing research and development, potentially leading to more efficient drug discovery and development processes. AI transformation can enhance decision-making, streamline operations, and foster innovation, which is vital for maintaining competitive advantage in the pharmaceutical industry. As AI continues to evolve, companies that successfully integrate these technologies may see improved outcomes in product development and market positioning, benefiting both the industry and consumers.
